| ATCC 27865| ATCC 35586 [[Carnobacterium piscicola]]| Carnibacterium piscicola| Carnobacterium maltaromaticum| Carnobacterium maltaromaticum (Miller et al. 1974) Mora et al. 2003| Carnobacterium maltaromicus| Carnobacterium piscicola| Carnobacterium piscicola (Hiu et al. 1984) Collins et al. 1987| CCUG 30142| CIP 103135| DSM 20342| DSM 20722 [[Lactobacillus carnis Shaw and Harding 1986]]| DSM 20730| JCM 1154| JCM 5348 [[Carnobacterium piscicola]]| JCM 9135 [[Lactobacillus carnis Shaw and Harding 1986]]| Lactobacillus carnis| Lactobacillus carnis Shaw and Harding 1986| Lactobacillus maltaromicus| Lactobacillus maltaromicus Miller et al. 1974 (Approved Lists 1980)| Lactobacillus piscicola| Lactobacillus piscicola Hiu et al. 1984| LMG 6903| LMG 9839 [[Carnobacterium piscicola]]| LMG 9840 [[Lactobacillus carnis Shaw and Harding 1986]]| LMG:6903| LMG:9839 [[Carnobacterium piscicola]]| LMG:9840 [[Lactobacillus carnis Shaw and Harding 1986]]| NBRC 15684 [[Carnobacterium piscicola]]| NCDO 2762 [[Carnobacterium piscicola]]| NCIMB 2264 [[Carnobacterium piscicola]]| NRRL B-14829 [[Carnobacterium piscicola]]| NRRL B-14852| strain LV 61 [[Lactobacillus carnis Shaw and Harding 1986]]| strain LV61 [[Lactobacillus carnis Shaw and Harding 1986]]
Antibiotic Production: Streptomyces lincolnensis produces lincomycin, a lincosamide antibiotic. Lincomycin is effective against a wide range of Gram-positive bacteria, including staphylococci, streptococci, and anaerobic bacteria. It is used clinically to treat various infections, including skin and soft tissue infections, respiratory tract infections, and infections caused by anaerobic bacteria.
Clinical Applications: Lincomycin, produced by Streptomyces lincolnensis, has been used clinically for many years to treat bacterial infections in humans and animals. However, its use is now more limited due to the availability of other antibiotics and concerns about antibiotic resistance and side effects.
Antibiotic Resistance Studies: Streptomyces lincolnensis and its antibiotic, lincomycin, have been studied in the context of antibiotic resistance. Understanding the mechanisms of action and resistance to lincomycin can provide insights into combating antibiotic resistance in bacteria.
Biotechnological Applications: Lincomycin and its derivatives may have various biotechnological applications beyond medicine. They may be used in agriculture as growth promoters for livestock or in industry for the production of semi-synthetic antibiotics.
Environmental Health: Streptomyces lincolnensis, like other Streptomyces species, plays roles in soil ecology and nutrient cycling, which indirectly impact human health through ecosystem services such as soil fertility and environmental sustainability.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
![]() |
NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 0.18 | 5 | 50 | 0 | 64 | 24.3 | 21 | 20.1 | 5 | 50 | 16.7 %ile | 66.7 %ile | ||
biomesight | 0.17 | 10 | 30 | 4 | 36 | 20 | 20 | 8.2 | 10 | 30 | 16.7 %ile | 66.7 %ile | ||
thorne | 55.17 | 1 | 10 | 0 | 10 | 4.9 | 4 | 2.7 | 1 | 10 | 0 %ile | 100 %ile | ||
ubiome | 0.25 | 21 | 43 | 2 | 62 | 32 | 32 | 15.6 | 21 | 43 | 25 %ile | 50 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
Thorne (20/80%ile) | 0 | 1.33 | 0 | 0.0001 |
PrecisionBiome | 1.7010914234560914E-05 | 0.00025573893799446523 | 0 | 0 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 0.086 % | 0.002 % | 0.001 % | 4.0 | 4653 |
CerbaLab | 66.667 % | 0.001 % | 0 % | 2.0 | 3 |
es-xenogene | 6.25 % | 0.004 % | 0.001 % | 2.0 | 32 |
Precision | 25 % | 0.001 % | % | 1.0 | 4 |
Thorne | 47.405 % | 0 % | 0 % | 137.0 | 289 |
uBiome | 0.249 % | 0.003 % | 0.002 % | 2.0 | 802 |
|
And display level must be raised above public.
Data comes from FoodMicrobionet. For the meaning of weight, see that site. The bacteria does not need to be alive to have an effect.